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Introduction
Early studies 1, 2 showed that the constituents of mucus are derived from goblet cells and the submucosal glands. Coles and coworkers 3 using 14 C-glucosamine, measured radiolabelled glycoprotein in the tissue medium from airway preparations and demonstrated that the epithelium did not contribute to the basal secretion in dog respiratory tract. However, removal of the epithelium significantly decreased the secretion of sulphated glycoprotein 2 suggesting that some secretory constituents may originate from the goblet cells in the epithelial layer. In contrast, Sasaki and coworkers 4 demonstrated that in cat airways the epithelium modulated the secretory activity of the submucosal glands.
Since the epithelium decreased the methacholine induced glandular secretion, these authors suggested the liberation of an epithelium inhibitory factor which modulated the mucin release. In contrast, Sherman and coworkers 5 using methacholine demonstrated a significant release of mucus glycoproteins in the absence of the epithelium. These latter results would suggest that the epithelium does not contribute significantly to the glycoproteins secreted. While some of these differences may be related to the species in which the ex periments were performed, there is little information available on the influence of the epithelium in modulating the secretory activity in human airways.
While the principal constituents of mucus are the mucins, a variety of proteins, glycoconjugates (serum type glycoproteins and proteoglycans) and glycolipids are also produced and secreted. 6 -8 In an attempt to characterize those factors w hich constitute respiratory secretion, Saint George and coworkers 9 showed that a number of monoclonal antibodies reacted w ith material in goblet cells and/or submucosal mucus gland cells, data which have been confirmed by other investigators. 10 Recently, Emery and coworkers 11 have prepared an anti-human mucin MAb against purified human respiratory mucins. These authors indicated that this anti-human MAb 3D3 was not specific for respiratory mucin but reacted, in fact, strongly with the Lewis b (Le b ) antigen, but also recognized Le a and Le y determinents using synthetic oligosaccharides. These investigators also demonstrated that in human airways the MAb 3D3 stained goblet cells and mucous cells of the submucosal glands as well as human epithelial cells in culture. 12 These observations suggested that this monoclonal may be a useful tool to monitor secretory activity in human airways.
The aim of this study was to examine glycoconjugate secretion in human airways in vitro under basal conditions and subsequent to methacholine stimulation. In order to evaluate the role of the epithelium, these experiments were performed in human bronchial ring preparations w ith an intact epithelium or in bronchial rings in which the epithelium had been removed.
Materials and Methods

Tissues
Human lung tissues was obtained from patients (n = 34) who had undergone surgery for lung carcinoma. Subsequent to the resection of lung, the subsegmental bronchi were dissected free from parenchymal tissue and washed with Tyrode's solution. The composition of the Tyrode's solution was (mM): NaCl 139.2, KCl 2.7, CaCl 2 1.8, MgCl 2 0.49, NaHCO 3 11.9, NaH 2 PO 4 0.4 and glucose 5.5 pH 7.4. Bronchial tissues were cut as rings (4-7 mm, internal diameter and 100-400 mg, wet weight). Bronchial preparations with and without epithelium were examined. The epithelium was removed by gently rubbing the luminal surface of the bronchial preparations w ith a moistened cotton swab.
Histological studies
Bronchial rings were fixed in formalin for 24 h, dehydrated, emdedded in parafin and sections (10 m m) were cut and stained with haematoxylin and eosin (2.5%) to evaluate general morphology.
The method for peroxidase staining was performed as previously described, 13 using Dako Kit LSAB-2. Briefly, tissue sections were deparaffinized w ith toluene, rehydrated with ethanol and washed w ith PBS. Endogenous peroxydases were eliminated w ith H 2 O 2 (3% for 5 min). Tissue sections were treated with blocking serum (casein 0.25% in PBS; Dako) for inhibition of cross immunological reactions. The tissues were incubated (10 min) w ith anti-mucin 3D3 antibody and washed with PBS. Thereafter, the sections were incubated (10 min) with peroxidase coupled to streptavidine and peroxidase activity was developed using diaminobenzidine/H 2 O 2 . Tissues were counter-stained with Harris haematoxylin.
Functional studies
The preparations were set up in a microtitre plate (24 wells) containing Tyrode's solution (1 ml) and allowed to equilibrate for 1 h in a humidified incubator (37°C, 5% CO 2 /air). At the end of this equilibration period, the medium was exchanged and fresh Tyrode's solution was added. The tissues were then maintained for 1 hour (Period I: basal release). The medium was collected and replaced w ith Tyrode's solution or Tyrode's solution containing atropine (100 m M). After 30 min (treatment), the medium was exchanged w ith Tyrode's solution or Tyrode's solution containing either atropine (100 m M) and/or methacholine (100 m M). In some experiments, subsequent to the incubation in Tyrode's solution (30 min) the bronchial preparations were stimulated with either LTD 4 (10 m M) or anti-IgE (dilution 1/1000). Following a 1 h exposure to these agents (Period II: post-treatment), the supernatants were again collected. The supernatants from Period I and Period II were stored at -20°C. Prior to determination of glycoconjugates (ELISA), dithiotreitol (DTT) 0.1% in PBS solution was added to these samples for 15 min at 37°C 14 to permit solubilization of mucus particulates present in the supernatants.
Glycoconjugate determination
The antigen and MAb 3D3 were a gift from Bayer plc (UK) and details concerning purification and preparation have recently been published. 11 The glycoproteins secreted in supernatants of human bronchial rings were detected by ELISA using the MAb 3D3. Microplates (Nunc-Immunoplate Maxisorp) were coated with a solution of MAb (dilution: 1/5000 in PBS) and incubated overnight at 4°C. The plates were washed tw ice with 200 µl of PBS-Tween 20 (dilution: 1/1000) employing a microplate washer, unbound sites were blocked with (30 mg/ml) BSA diluted in PBS for 1 h at 37°C. The plates were washed with a dilution of purified human 3D3 antigen standard in PBS-Tween-20 (1-500 ng/50 m l) and the supernatants of the bronchial ring preparations were distributed in the wells and incubated for 1 h at 37°C. Following, three washes with Tris -Tween-20, the MAb 3D3 mix ed with normal mouse serum and antimouse immunoglobulin IgG conjugated with alkaline phosphatase (1/500 in Tris-polyethylenglycol (PEG at 4%) was added to wells and incubated for 1 h at 37°C. The plates were washed tw ice with TrisTween-20 and developed using a solution of p-nitrophenylphosphate (pNpp) diluted in 0.2 M Tris buffer pH > 8 to give a final concentration (1mg/ml) substrate. The reaction was terminated (15-20 min) when the optical densities (OD) correspond to maximal concentration from 3D3 antigen standard attained 0.8 OD units. Optical densities were measured with a Titertek-Multiskan (Labsystems) microplate reader using a wavelength of 405 nm. The amount of glycoconjugate released was interpolated from the 3D3 antigen standard curve. A standard curve w ith dithiotreitol was carried with different amount of 3D3 antigen (1-250 ng/50 m l), the dithiotreitol (0.1%) was added to the maximal concentration of antigen and serial dilutions were subsequently performed. Since the monoclonal antibody 3D3 is directed specifically against the 
Source of products
Plates (maxi-sorp Nunc), Tris (Prolabo), polyethylene glycol 6000 (Merck), Kit LSAB-2 for immunolabelling containing diaminobenzidine (Dako Laboratories). All the remaining products; methacholine, atropine, mouse serum, anti-mouse immunoglobulin coupled with alkaline phosphatase, bovine serum albumin, dithiotreitol (DTT), Tween-20, p-nitrophenylphosphate (pNpp) were from Sigma Chemical Co., USA. The LTD 4 was a gift from Dr P. J. Gardiner (Bayer plc).
The sheep antiserum to human IgE (anti-IgE) was obtained from Nordic Immunological Laboratories, Tilberg, the Netherlands.
Calculation
The data are represented as (m g/g tissue) or (% of basal level, that is, Period II/Period I 3 100). All results are means ± SEM and n indicates the number of lung samples. Statistical analysis was performed using Student's t-test or Mann-Whitney rank sum test.
A value (P < 0.05) was taken as an indication of significance.
Results
Histological data
Mechanical removal of the epithelium by rubbing the luminal surface of human isolated bronchial ring preparations led to the complete obliteration of the epithelium w hile the basement membrane was left intact (Fig. 1) . In human bronchial ring preparations after treatment with MAb 3D3, staining showed that this MAb 3D3 antibody was associated with tw o specific tissue regions, namely, the epithelial layer and submucosal glands (Fig. 2) .
Functional data
The DTT did not alter the 3D3 antigen standard curve (Fig. 3.) . In 11 of the 34 different lung samples studied in this assay (32%), the glycoconjugate levels were below the threshhold level of detection. The mean basal secretion of glycoconjugates in human airways in vitro was 100 ± 28 m g/g tissue (Period I; n = 23 different lung samples). The amount of glycoconjugate measured in the medium, derived from human isolated bronchial ring prepara- tions, did not change under control conditions during the course of the experimental procedure (Period I; 128 ± 46 m g/g tissue and Period II; 159 ± 48 m g/g tissue; n = 13 paired lung samples). In the supernatants of airway preparations w ith an intact epithelium the amount of glycoconjugates detected was 90 ± 38 m g/g tissue (Period I; n = 12 different lung samples) and removal of the epithelium did not alter this basal glycoconjugate release (94 ± 60 m g/g tissue: Period I, n = 8 different lung samples). The absence of the epithelial layer was confirmed by histological evaluation.
In human isolated bronchial ring preparations w ith an intact epithelium methacholine (100 m M) produced a significant increase in the amount of glycoconjugate detected in the medium (Fig. 4) . In contrast, no significant change was observed in human bronchial preparations stimulated w ith either LTD 4 (10 m M; n = 3, 48 ± 24%) or anti-IgE (dilution 1/1000; n = 5, 76 ± 17%). The 10-fold increase in glycoconjugate release induced by methacholine was attenuated by atropine (100 m M). Results derived from similar experiments performed in bronchial rings where the epithelium had been removed are presented in Fig. 5 . These data demonstrate that removal of the epithelium did not significantly alter either the basal or stimulated levels of glycoconjugate in the tissue medium.
Discussion
MAb 3D3, a marker of secretory glycoconjugates 11, 12 was used to determine glycoconjugate release in human airways in vitro. Histochemical analysis revealed that the glycoconjugates which reacted w ith MAb 3D3 were associated w ith both the epithelium and the glandular mucus cells of the human bronchus. Methacholine appeared to be the most effective agent to stimulate glycoconjugate release in this model. In addition, the amounts of glycoconjugates detected (basal and stimulated levels) as measured with the MAb 3D3 were not dependent on the presence of the epithelium since removal of this layer did not significantly alter either the basal or methacholine induced release. Stahl and Ellis 2 published a biochemical study showing that removal of the epithelium in dog airways permitted the detection of several glycoproteins thereby assigning the release of different substances to the epithelium or the mucosal glands of the respiratory tract of this species. Removal of the epithelium produced a significant decrease in the secretion of sulphated glycoproteins suggesting that goblet cells in the epithelium were responsible for these constituents. In addition, these authors also showed that while the epithelial layer and the mucosal glands secrete different macromolecules, they also interacted in the formation of the larger glycoconjugates w hich are released into the airway lumen.
Previous reports in human airway tissues 6, 10, 14 have demonstrated that there was little or no change in basal secretion under control conditions, however, methacholine induced significant increases in secretory activity. The results (present report) confirm these initial observations and are in agreement w ith data derived from other species, such as the cat. In contrast, in this model (present report) LTD 4 and antiIgE did not induce glycoconjugate release. These results are different from previous reports where secretory activity was assessed using radioactive markers. Marom and coworkers 15 showed a small increase in release from human airways in vitro (40% above control levels) using either LTC 4 or LTD 4 . These data were also supported by the investigation of Coles and coworkers 16 who demonstrated a similar leukotriene-induced secretory release from human airways. However, radioactive elements may be incorporated into several cells and mark a variety of molecules, 17 these differences in results may be explained in part by the specificity of the markers employed to determine secretory activity.
However, removal of the epithelium did not significantly modify either the basal secretion or that induced by methacholine stimulation (present report) when the MAb 3D3 was used to evaluate glycoconjugate release from human airways. Therefore species differences may also exist since Sasaki and coworkers 4 showed that in the respiratory tract of the cat the epithelium modified the secretory activity of the submucosal glands. The data from human airways (present report) would also suggest that the methacholine is acting principally at the glandular level. The lack of cholinergic response at the goblet cell level may be due to the absence of neuronal inputs 18 at the surface epithelium. In addition, Mak and Barnes 19 using an autoradiographic technique in human airways demonstrated that muscarinic receptors were not detected in the epithelial layer, since no radiolabel was observed, although label was detected in the region of the glands. Such results would suggest that muscarinic receptors may not be present in the epithelium in human airways. However, a recent publication has demonstrated that muscarinic receptor mRNA is detected in the human respiratory epithelium. 20 While the autoradiographic technique may not provide adequate sensitivity to detect muscarinic receptors, their location and function in the epithelium has not been adequately evaluated.
While initial reports showed that epithelial cells in culture fail to secrete mucin and/or mucin-like glycoproteins, 2 recent studies using human epithelial cells in culture have demonstrated that a number of substances including mucins could be detected after several weeks in culture. 12 While these investigators demonstrated that epithelial cells in culture were stained with the MAb 3D3, no indication as to the function of these epithelial cells was examined. The data from intact human airways in vitro (present report) extend the work of Emery and coworkers 11 and demonstrate that the MAb 3D3 may also be used to detect basal and methacholine induced secretory activity. However, the functional studies (present report) suggest that while the epithelial layer may fix the MAb 3D3, there was little or no secretory activity detected by MAb 3D3 from this layer. In addition, removal of the epithelium did not modulate either the basal or stimulated release of glycoconjugates in human airway preparations. 
